Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Cdc7 inhibitor.
Inhibitor of VEGFR and FGFR.
Polyphenolic compound present in black tea.
NLRP3 and caspase-1 inhibitor.
p53 activator, IMPDH and SIRT1 inhibitor.
PLK1 inhibitor.
FIASMA, μOR agonist, potential HCN channel blo...
NMDA NR1/NR2B antagonist.
Dual kinase and GTPase inhibitor.
Taxol derivative.
Antineoplastic immunomodulator.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
p38 MAPK inhibitor.
Catechol-type flavonoid; fatty acid synthesis i...
Triterpene saponin found in species of Panax.
Peptide found in molluscs, cardiomodulator.
Wortmannin analog; PI3K inhibitor.
Mas antagonist.
NSAID; COX-1/2 inhibitor.
Used to study embryonic cloning; microtubule po...